Correction: Relative Bioavailability of Dolutegravir (DTG) and Emtricitabine/Tenofovir Alafenamide Fumarate (F/TAF) Administered as Paediatric Tablet Formulations in Healthy Volunteers.

Bevers, Lisanne A H; Kamphuis, Anne E M; van der Wekken-Pas, L C Wendy; Leisegang, Rory; Burger, David M; Colbers, Angela

Bevers, Lisanne A H; Kamphuis, Anne E M; van der Wekken-Pas, L C Wendy; Leisegang, Rory; Burger, David M; Colbers, Angela.

Afiliação

Bevers LAH; Department of Pharmacy (route 864), Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands. Lisanne.Bevers@radboudumc.nl.
Kamphuis AEM; Department of Pharmacy (route 864), Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
van der Wekken-Pas LCW; Department of Pharmacy (route 864), Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
Leisegang R; Clinical Pharmacology, Paediatric Centre of Excellence, Gilead Sciences, Dublin, Ireland.
Burger DM; Department of Pharmacy (route 864), Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
Colbers A; Department of Pharmacy (route 864), Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.

Clin Pharmacokinet ; 63(5): 729-730, 2024 May.

Article em En | MEDLINE | ID: mdl-38696004

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Pharmacokinet Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google